Navigation Links
Convoy Catheter Introducer Sheaths

ProductsConvoy Catheter Introducer Sheaths
Company Boston Scientific Corporation
Item Convoy Catheter Introducer Sheaths
Features 
  • Soft tip sheath engineering provides atraumatic access, smooth delivery and removal of an Ultra ICE, Constellation or other EP catheter.
  • Wire braided shaft designed for enhanced torque and manueverability
  • providing easier cannulation and minimized kinking.
    • Description The soft tip sheath design for smooth delivery and retrieval of Constellation advanced mapping basket catheters.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. Lumboperitoneal Catheter and Shunt Systems
    2. Bactiseal EVD Catheter
    3. Atlantis SR Pro Coronary Imaging Catheter
    4. Atlantis SR Plus Catheter
    5. Maverick Over-The-Wire 9 mm Catheter
    6. Maverick Over-The-Wire 12 mm Catheter
    7. Maverick Over-The-Wire 15 mm Catheter
    8. Maverick Over-The-Wire 20 mm Catheter
    9. Maverick Over-The-Wire 25 mm Catheter
    10. Maverick Over-The-Wire 30 mm Catheter
    11. Trak Back II Catheter Pull-Back Device
    The CHLAYMDIA OIA test delivers 100% specificity and 100% PPV with test results in 19 minutes. With as many as one-fourth of patients not returning for follow-up, this assay provides a test & treat
    Shielding's Wrap-Around Apron is designed for front and back protection. This apron features extra wide shoulders distributing weight over a greater area to reduce fatigue.
    Shielding's Velcro Adjustable Apron has two velcro flaps which aid in relieving weight off the shoulders. Its comfortable fit is attained by varying the position of flaps.
    Upper arm protection
    Medicine Products:
    (Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
    (Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
    (Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
    (Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
    Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
    ...y reveals that Bupropion is an effective treatment...n or nerve pain is commonly treated with tricycli... effects and don't always relieve the burning, sta...ated with nerve pain. Now researchers at the Univ...
    ...ccur in several forms, but systemic lupus erythema...is the most serious type. It is an incurable disea... organs throughout the body, including the joints,... Lupus is an autoimmune disorder, meaning the immu...
    ...ng could effectively create a replica of another l...first cloned human before the end of the year. Dr....eague Dr. Severino Antinori has triggered worldwid...de offspring. Countries like France and Germany ha...
    ...me, also known as trisomy 21, is a chromosomal dis...irths. The condition produces varying degrees of m...ies, including a small nose and thick neck, which ...etecting Down syndrome early in pregnancy could be...
    Other Medicine News:
    (Date:9/5/2008)...wire/ -- When Michigan,s first chronic,wasting dis...eer farm in,Kent County, state and federal officia...r,s property and began the process of testing them...llowing statement on the negative CWD,test results... The deer farm industry today received welcome ne...
    (Date:9/5/2008)...ewswire-USNewswire/ -- Cancer patients,have compla...brain. Now in,animal studies at West Virginia Univ...s of N-acetyl cysteine (NAC), an antioxidant, can ...erapy drugs sometimes induce., In the WVU researc...he,journal Metabolic Brain Disease, rats were give...
    (Date:9/5/2008)...pt. 5 /- SARcode,Corporatio...-1 inhibitors,to treat inflammatory diseases, and ... announced SARcode,s initiation of a Phase 1 clini...ate for T-cell mediated ophthalmic,diseases. Sunes...oviding,SARcode with an exclusive license to Sunes...
    (Date:9/5/2008)...Extracted From a Simple Blood Draw Have,the Potent...a Wide Range of Indic...Genomics is Currently Developing a B...Israel and JERSEY CITY, New Jersey, September 5,/P...SDQ: ROSG), a leader in,the development of microRN...
    Breaking Medicine Technology:Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 2Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 3Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 1Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 2Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 3Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 4Milestone Scientific Hosts First International Computer Controlled Local Anesthetic Delivery 28CCLAD 29 Summit 13032 5CDC Vaccine Committee Recommends More Shots for Children 13030 1CDC Vaccine Committee Recommends More Shots for Children 13030 2Touch Bionics signs U S distribution agreement with SPS 3597 1Touch Bionics signs U S distribution agreement with SPS 3597 2Scientists Find Cancer Culprits in Cigarette Smoke 13028 1Scientists Find Cancer Culprits in Cigarette Smoke 13028 2
    ...wo studies presented,today demonstrated that Rozer... nor did it impair middle-of-the-night balance,mo...r from chronic,insomnia. The results of the studie... Associated Professional Sleep Societies,(APSS). ,...ROZEREM may be,a safe sleep medication for the man...
    ... in Signs and,Symptoms Of Moderate to Severe Rheum...ng Disease Remission at One-Year,Mark , BARCELON...nearly,75 percent of patients with moderate to sev...(CNTO 148) and methotrexate (MTX),experienced and ...ritis symptoms (ACR 20). This was according to fin...
    Other Medicine Technology:Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5